Tag: US market

Sun Pharma launches cancer drug in US market

NEW DELHI: Drug major Sun Pharmaceutical Industries on Monday announced launch of INFUGEM injection, used for treatment of cancer, in the US market. In July 2018, Sun Pharma had received approval from the US health regulator for INFUGEM injection. “INFUGEM (gemcitabine in sodium chloride injection), for intravenous use, is now commercially available in the US,” […]

Dr Reddy’s launches injection for anesthesia and sedation in US market

NEW DELHI: Dr Reddy’s Laboratories Thursday announced the launch of Propofol Injectable Emulsion, used for induction of general anesthesia and sedation in intensive care units, in the US market. Propofol Injectable Emulsion is a therapeutic equivalent generic version of Diprivan (Propofol) Injectable Emulsion,” the company said in a BSE filing. Dr Reddy’s said it uses […]

Back To Top